EVOK icon

Evoke Pharma
EVOK

Overview Fund Activity

30 hedge funds and large institutions have $6.75M invested in Evoke Pharma in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
30
Holders Change
+5
Holders Change %
+20%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
5
Closed
2
Calls
$703K
Puts
$381K
Net Calls
+$322K
Net Calls Change
-$210K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$1.3M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$483K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$111K
4
SM
4
Sabby Management
Florida
$168K
5
Group One Trading
5
Group One Trading
Illinois
$89K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
UBS Group
2
UBS Group
Switzerland
$5K
3
TRCT
3
Tower Research Capital (TRC)
New York
$3K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.66M
5
DWA
5
Dorsey Wright & Associates
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Federated Hermes
26
Federated Hermes
Pennsylvania
$3K +$1.13K +3 +60%
Osaic Holdings
27
Osaic Holdings
Arizona
$1K – – –
Citigroup
28
Citigroup
New York
$1K – – –
Deutsche Bank
29
Deutsche Bank
Germany
$1K +$1K +3 New
OSAM
30
O'Shaughnessy Asset Management
Connecticut
$1K +$1K +4 New
Citadel Advisors
31
Citadel Advisors
Florida
– -$108K -159 Closed
DWA
32
Dorsey Wright & Associates
California
– -$8K -11 Closed
1
2